Projects per year
Personal profile
Education
- 2010-2013 Ph.D., Biomedical Electronics and Bioinformatics, National Taiwan University Hospital
- 1981-1997 M.D., Department of Medicine, Chang-Gung University
Experience
- 2023.02- Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2023.02- Professor, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2021.08- Director, Division of Thoracic Medicine, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
- 2020.02-2023.01 Associate Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2020.02-2023.01 Associate Professor, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2019.08-2020.01 Assistant Professor, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2019.05-2019.07 Assistant Professor, Preparatory Office, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2014- Chief, Tuberculosis Center, Taipei Municipal Wanfang Hospital
- 2014.11 Attending Physician, Division of Pulmonary Medicine, Wanfang Hospital
- 2014.11-2020.01 Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2004-2013 Attending Physician, Taipei Tzu Chi Hospital
- 2003.07-2004.10 Attending Physician, Far Eastern Memorial Hospital
Awards
- 2019 Affiliated Hospital Research Project Award, Taipei Medical University
- 2014 Best reviewer of Pharmacoepidemiology and Drug Safety.
Research Interests
- Tuberculosis
- Chronic obstructive pulmonary disease
- Health Information Database
- Critical Care Medicine
Fingerprint
Dive into the research topics where Chih-hsin Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 5 Finished
-
Elucidating the Association of Toll-Like Receptor II Mediated Immune Cell Response and Susceptibility to Tuberculosises in Patients with Diabetes Mellitus
Lee, C.-H. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
分析結核病接觸者周邊血調節型T淋巴球與潛伏結核感染的關聯性-III
Lee, C.-H. (PI)
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
分析結核病接觸者周邊血調節型T淋巴球與潛伏結核感染的關聯性
Lee, C.-H. (PI)
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
分析結核病接觸者周邊血調節型T淋巴球與潛伏結核感染的關聯性
Lee, C.-H. (PI)
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
-
穿戴式裝置於老人及高風險結核病病人偵測因藥物導致的QT間距延長之能力探討
Lee, C.-H. (PI)
1/1/19 → 12/31/19
Project: C - Project of Alliance › j - National Taipei University of Technology
-
Concurrent Chinese and Western medication use and risk of acute exacerbations in chronic obstructive pulmonary disease: A national cohort study
Lee, M. C., Wu, C. Y., Chen, S. M., Chang, Y. H., Peng, T. R., Chen, J. H., Satake, S., Lee, J. A., Lee, C. H. & Wang, J. Y., Jun 2026, In: Integrative Medicine Research. 15, 2, p. 101286 101286.Research output: Contribution to journal › Article › peer-review
Open Access -
Personalized serum proteome profiles of COVID-19-associated acute respiratory distress syndrome in response to mesenchymal stem cell therapy
Putri, D. U., Chen, M. C., Weng, C. M., Kuo, H. P., Lee, C. H. & Han, C. L., Feb 2026, In: Journal of Microbiology, Immunology and Infection. 59, 1, p. 35-44 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis
Martinez, L., Campbell, J. I., Linde, L., Boulahbal, F., Cayla, J. A., Chakhaia, T., Chan, P. C., Chen, C., Fang, C. T., Fox, G., Grandjean, L., Hannoun, D., Hesseling, A., Horsburgh, C. R., Huang, L. M., Liu, Q., Mazahir, R., Lee, C. H., Lee, L. N. & Bennet, R. & 18 others, , Jan 1 2026, In: American Journal of Respiratory and Critical Care Medicine. 212, 1, p. 129-137 9 p.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Citations (Scopus) -
Treatment outcomes of high- and low-level isoniazid-resistant tuberculosis: Analysis from a Nationwide Pulmonary Tuberculosis Cohort
Chang, C. H., Lee, M. C., Keng, L. T., Chen, J. H., Lee, M. R., Lee, C. H. & Wang, J. Y., Aug 2026, In: International Journal of Infectious Diseases. 169, 108811.Research output: Contribution to journal › Article › peer-review
Open Access -
Xpert MTB/RIF assay as an initial diagnostic test in pulmonary tuberculosis: a multicenter prospective randomized pragmatic trial
Huang, W. C., Huang, Y. W., Lin, C. B., Chien, S. T., Lee, C. H., Yu, M. C., Lee, J. J. & Chiang, C. Y., Dec 2026, In: Scientific Reports. 16, 1, 10075.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Additional file 4: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Contributor), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119192.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119192/1
Dataset
-
Additional file 3: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Contributor), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119174.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119174/1
Dataset
-
Additional file 1: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Creator), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.6119126.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119126/1
Dataset
-
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Creator), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4063952.v1, https://figshare.com/collections/Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/4063952/1
Dataset
-
Additional file 5: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Contributor), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119204.v1, https://springernature.figshare.com/articles/Additional_file_5_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119204/1
Dataset